The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Decompensated cirrhosis and antibiotic prophylaxis: striking a delicate balance

  • Jung Gil Park (Department of Internal Medicine, Yeungnam University College of Medicine)
  • Received : 2024.04.08
  • Accepted : 2024.04.20
  • Published : 2024.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Fernandez J, Tandon P, Mensa J, Garcia-Tsao G. Antibiotic prophylaxis in cirrhosis: good and bad. Hepatology 2016;63:2019-2031. https://doi.org/10.1002/hep.28330
  2. Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014;60:1310-1324. https://doi.org/10.1016/j.jhep.2014.01.024
  3. Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010;139:1246-1256, 1256.e1-e5. https://doi.org/10.1053/j.gastro.2010.06.019
  4. Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012;56 Suppl 1:S1-S12. https://doi.org/10.1016/S0168-8278(12)60002-6
  5. Kulkarni AV, Tirumalle S, Premkumar M, et al. Primary norfloxacin prophylaxis for APASL-Defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial. Am J Gastroenterol 2022;117:607-616. https://doi.org/10.14309/ajg.0000000000001611
  6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. J Hepatol 2023;79:461-491.
  7. Louvet A, Labreuche J, Dao T, et al. Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial. JAMA 2023;329:1558-1566.
  8. Br VK, Sarin SK. Acute-on-chronic liver failure: terminology, mechanisms and management. Clin Mol Hepatol 2023;29:670-689. https://doi.org/10.3350/cmh.2022.0103
  9. Chaulk J, Carbonneau M, Qamar H, et al. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies. Can J Gastroenterol Hepatol 2014;28:83-88. https://doi.org/10.1155/2014/429536
  10. Kim A, Song BG, Goh MJ, et al. Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis. Korean J Intern Med 2024;39:448-457. https://doi.org/10.3904/kjim.2023.354
  11. Kim SW, Yoon JS, Park J, et al. Empirical treatment with carbapenem vs third-generation cephalosporin for treatment of spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 2021;19:976-986.e5. https://doi.org/10.1016/j.cgh.2020.06.046